全文获取类型
收费全文 | 153112篇 |
免费 | 10157篇 |
国内免费 | 4697篇 |
专业分类
耳鼻咽喉 | 1531篇 |
儿科学 | 2309篇 |
妇产科学 | 1470篇 |
基础医学 | 15178篇 |
口腔科学 | 11379篇 |
临床医学 | 14055篇 |
内科学 | 13337篇 |
皮肤病学 | 1313篇 |
神经病学 | 5547篇 |
特种医学 | 6128篇 |
外国民族医学 | 30篇 |
外科学 | 31175篇 |
综合类 | 25198篇 |
现状与发展 | 8篇 |
一般理论 | 4篇 |
预防医学 | 9155篇 |
眼科学 | 1621篇 |
药学 | 11910篇 |
194篇 | |
中国医学 | 11701篇 |
肿瘤学 | 4723篇 |
出版年
2024年 | 336篇 |
2023年 | 2286篇 |
2022年 | 4141篇 |
2021年 | 6301篇 |
2020年 | 5569篇 |
2019年 | 5145篇 |
2018年 | 4630篇 |
2017年 | 4766篇 |
2016年 | 4824篇 |
2015年 | 4745篇 |
2014年 | 9467篇 |
2013年 | 9988篇 |
2012年 | 8368篇 |
2011年 | 9783篇 |
2010年 | 8590篇 |
2009年 | 7317篇 |
2008年 | 6758篇 |
2007年 | 7061篇 |
2006年 | 6434篇 |
2005年 | 5812篇 |
2004年 | 4902篇 |
2003年 | 4216篇 |
2002年 | 3283篇 |
2001年 | 2890篇 |
2000年 | 2361篇 |
1999年 | 2119篇 |
1998年 | 1733篇 |
1997年 | 1686篇 |
1996年 | 1414篇 |
1995年 | 1302篇 |
1994年 | 1233篇 |
1993年 | 944篇 |
1992年 | 906篇 |
1991年 | 816篇 |
1990年 | 677篇 |
1989年 | 637篇 |
1988年 | 615篇 |
1987年 | 498篇 |
1986年 | 473篇 |
1985年 | 1317篇 |
1984年 | 1464篇 |
1983年 | 1553篇 |
1982年 | 1622篇 |
1981年 | 1503篇 |
1980年 | 1286篇 |
1979年 | 1328篇 |
1978年 | 956篇 |
1977年 | 721篇 |
1976年 | 464篇 |
1975年 | 243篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
《Saudi Pharmaceutical Journal》2022,30(11):1572-1588
Non-alcoholic fatty liver disease (NAFLD) is one of the most common complications of a metabolic syndrome caused by excessive accumulation of fat in the liver. Orthosiphon stamineus also known as Orthosiphon aristatus is a medicinal plant with possible potential beneficial effects on various metabolic disorders. This study aims to investigate the in vitro inhibitory effects of O. stamineus on hepatic fat accumulation and to further use the computational systems pharmacology approach to identify the pharmacokinetic properties of the bioactive compounds of O. stamineus and to predict their molecular mechanisms against NAFLD. Methods: The effects of an ethanolic extract of O. stamineus leaves on cytotoxicity, fat accumulation and antioxidant activity were assessed using HepG2 cells. The bioactive compounds of O. stamineus were identified using LC/MS and two bioinformatics databases, namely the Traditional Chinese Medicine Integrated Database (TCMID) and the Bioinformatics Analysis Tool for the Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM). Pathway enrichment analysis was performed on the predicted targets of the bioactive compounds to provide a systematic overview of the molecular mechanism of action, while molecular docking was used to validate the predicted targets. Results: A total of 27 bioactive compounds corresponding to 50 potential NAFLD-related targets were identified. O. stamineus exerts its anti-NAFLD effects by modulating a variety of cellular processes, including oxidative stress, mitochondrial β-oxidation, inflammatory signalling pathways, insulin signalling, and fatty acid homeostasis pathways. O. stamineus is significantly targeting many oxidative stress regulators, including JNK, mammalian target of rapamycin (mTOR), NFKB1, PPAR, and AKT1. Molecular docking analysis confirmed the expected high affinity for the potential targets, while the in vitro assay indicates the ability of O. stamineus to inhibit hepatic fat accumulation. Conclusion: Using the computational systems pharmacology approach, the potentially beneficial effect of O. stamineus in NAFLD was indicated through the combination of multiple compounds, multiple targets, and multicellular components. 相似文献
3.
《Journal of cranio-maxillo-facial surgery》2022,50(3):225-229
The aim of this study was to investigate the clinical course of masticatory function recovery following arthrocentesis. Patients with a unilateral condylar head fracture who underwent arthrocentesis for therapeutic reasons were evaluated and compared with patients with a unilateral condylar head fracture who did not undergo arthrocentesis. At 3 months after treatment, the occlusal contact area and maximum bite force in patients with a fracture treated with arthrocentesis were greater than in those who did not receive arthrocentesis at the same time points, although the differences were not significant. Moreover, at 1 and 3 months following arthrocentesis, mean (±SD) occlusal contact area (1 month: 1.99 ± 0.55 mm2, p = 0.01; 3 months: 2.90 ± 1.36 mm2, p = 0.03) and maximum bite force (1 month: 82.45 ± 15.04 N, p = 0.01; 3 months: 101.11 ± 14.53 N, p = 0.01) on the fractured side in patients who underwent that treatment were significantly reduced when compared with those on the non-fractured side. The authors conclude that if the priority is to avoid open reduction and internal fixation, then the arthrocentesis approach might be a less invasive alternative, albeit with the price of a prolonged healing interval. 相似文献
4.
5.
6.
7.
8.
9.
10.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献